João Pedro Ferreira, John G F Cleland, Carolyn S P Lam, Dirk J van Veldhuisen, William M Byra, David A La Police, Stefan D Anker, Mandeep R Mehra, Céline Leroy, Valerie Eschwege, Marie Toussaint-Hacquard, Patrick Rossignol, Barry Greenberg, Faiez Zannad
OBJECTIVES: This study sought to compare patient characteristics, outcomes, and treatment effects among regions in the COMMANDER-HF trial. BACKGROUND: Globalization of cardiovascular trials increases generalizability. However, regional differences may also introduce heterogeneity in results. METHODS: Incidence rates and interactions with treatment were recorded in pre-specified regions: Eastern Europe, Western Europe and South Africa, North America, Asia-Pacific, and Latin America...
March 2021: JACC. Heart Failure